BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol 1998;20:455-91. [PMID: 9870257 DOI: 10.1007/BF00838055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med 2004;200:1623-33. [PMID: 15611290 DOI: 10.1084/jem.20040890] [Cited by in Crossref: 296] [Cited by in F6Publishing: 242] [Article Influence: 18.5] [Reference Citation Analysis]
2 Shaffer DR, Rooney CM, Gottschalk S. Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation. Immunotherapy 2010;2:663-71. [PMID: 20874650 DOI: 10.2217/imt.10.43] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant 2009;15:1609-19. [PMID: 19744572 DOI: 10.1016/j.bbmt.2009.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mir MA, Battiwalla M. Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Mycopathologia 2009;168:271-82. [PMID: 19156534 DOI: 10.1007/s11046-009-9181-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
5 Nikiforow S, Bottomly K, Miller G, Münz C. Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 2003;77:12088-104. [PMID: 14581546 DOI: 10.1128/jvi.77.22.12088-12104.2003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]